Update of Radiofrequency Ablation for Treating Benign and Malignant Thyroid Nodules. The Future Is Now

the International Head and Neck Scientific Group

Research output: Contribution to journalReview articlepeer-review

Abstract

Thermal and chemical ablation are minimally invasive procedures that avoid removal of the thyroid gland and target symptomatic nodules directly. Internationally, Radiofrequency ablation (RFA) is among one of the most widely used thermal ablative techniques, and is gaining traction in North America. Surgery remains the standard of care for most thyroid cancer, and in the right clinical setting, Active Surveillance (AS) can be a reasonable option for low risk disease. Minimally invasive techniques have emerged as an alternative option for patients deemed high risk for surgery, or for those patients who wish to receive a more active treatment approach compared to AS. Herein, we review the literature on the safety and efficacy of RFA for treating benign non-functioning thyroid nodules, autonomously functioning thyroid nodules, primary small low risk thyroid cancer (namely papillary thyroid cancer) as well as recurrent thyroid cancer.

Original languageEnglish (US)
Article number698689
JournalFrontiers in Endocrinology
Volume12
DOIs
StatePublished - Jun 24 2021

Keywords

  • autonomously functioning thyroid nodules
  • benign thyroid nodules
  • primary thyroid cancer
  • radiofrequency ablation
  • recurrent thyroid cancer
  • thermal ablation

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint

Dive into the research topics of 'Update of Radiofrequency Ablation for Treating Benign and Malignant Thyroid Nodules. The Future Is Now'. Together they form a unique fingerprint.

Cite this